loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient combination of emtricitabine, rilpivirine and tenofovir disoproxil (ATC code J05AR08). - 67483

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient combination of emtricitabine, rilpivirine and tenofovir disoproxil (ATC code J05AR08). - 67483 has been published on Bidding Source portal dated 03 Feb 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient combination of emtricitabine, rilpivirine and tenofovir disoproxil (ATC code J05AR08). - 67483
Invitation for Bids
Germany
3 Feb 2025
25 Jan 2027
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient oxycodone/naloxone (ATC code according to WHO: N02AA55) - 62173 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient amifampridine (ATC code: N07XX05). - 64471 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient nitisinone (ATC code: A16AX04). - 63672 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient beclometasone/formoterol (ATC code according to WHO: R03AK08) - 57048 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 of the Social Code Book V with the active ingredient Rivaroxaban in the dosage form HKP - 59891 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient aripiprazole for parenteral administration (ATC code according to WHO: N05AX12) - 48010 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient Natalizumab (ATC code according to WHO: L04AG03) - 47685 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V in the period from 01.03.2025 to 31.12.2026 - 47306 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient Rivaroxaban (ATC code according to WHO: B01AF01) - 49081 Germany Open House Original Discount Contracts 2025-01 - Bictegravir/Emtricitabine/Tenofovir alafenamide (Biktarvy(R)) - 39458 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans